SCHEMBL7537876

SCHEMBL7537876

CC(=NO)c1ccc(Cl)c(Cl)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPFFR2 Q9Y5X5 1/20 0.61
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ GAA P10253 2/20 0.53
▸ CA9 Q16790 1/20 0.53
▸ ATM Q13315 1/20 0.49
▸ TSHR P16473 1/20 0.48
▸ POLB P06746 1/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ GFER P55789 1/20 0.47
▸ SENP8 Q96LD8 1/20 0.47
▸ SENP7 Q9BQF6 1/20 0.47
▸ SENP6 Q9GZR1 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3228942 1.00 NPFFR2 (0.61) NPFFR2MEN1KMT2ASMN1; SMN2GAA
Acetic Acid SCHEMBL8204105 0.92 MEN1 (0.66) NPFFR2MEN1KMT2ASMN1; SMN2GAA
SCHEMBL6811431 0.78 NPFFR2 (0.56) NPFFR2MEN1KMT2ASMN1; SMN2GAA
SCHEMBL6811427 0.78 NPFFR2 (0.56) NPFFR2MEN1KMT2ASMN1; SMN2GAA
SCHEMBL8803664 0.77 TSHR (0.56) NPFFR2MEN1KMT2ASMN1; SMN2GAA
SCHEMBL3763127 0.76 TSHR (0.52) NPFFR2MEN1KMT2ASMN1; SMN2GAA
SCHEMBL3763124 0.76 TSHR (0.52) NPFFR2MEN1KMT2ASMN1; SMN2GAA
SCHEMBL11774103 0.76 TSHR (0.50) NPFFR2MEN1KMT2ASMN1; SMN2GAA
SCHEMBL8149124 0.76 TSHR (0.50) NPFFR2MEN1KMT2ASMN1; SMN2GAA
SCHEMBL8149125 0.76 TSHR (0.50) NPFFR2MEN1KMT2ASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112574135-B 4-aryl-5-thioether-2-difluoromethyl oxazole, and derivatives and synthesis method thereof 湖南工程学院 2022-09-23 — — CN claimed
CN-112574135-A 4-aryl-5-thioether-2-difluoromethyl oxazole, and derivatives and synthesis method thereof 湖南工程学院 2021-03-30 — — CN claimed
CN-112574135-B 4-aryl-5-thioether-2-difluoromethyl oxazole, and derivatives and synthesis method thereof 湖南工程学院 2022-09-23 — — CN disclosed
CN-112574135-A 4-aryl-5-thioether-2-difluoromethyl oxazole, and derivatives and synthesis method thereof 湖南工程学院 2021-03-30 — — CN disclosed
EP-2927218-B1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2018-07-04 — — EP disclosed
US-9725423-B2 Tetrazolinone compound and applications thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-08-08 — — US disclosed
US-20150299146-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-22 — — US disclosed
EP-2927218-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-07 — — EP disclosed
WO-2014084223-A1 TETRAZOLINONE COMPOUND AND USE THEREOF 住友化学株式会社 (JP) 2014-06-05 — — WO disclosed
US-20120329812-A1 CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF CHDI FOUNDATION, INC. 2012-12-27 — — US disclosed
CN-1094487-C Oxime derivative and fungicide containing the same as active ingredient SHIONOGI & CO (JP) 2002-11-20 — — CN disclosed
US-6075148-A CARBAMATE DERIVATIVES ARE USEFUL FOR CONTROLLING FUNGI, INSECTS, NEMATODES AND SPIDER MITES BASF AKTIENGESELLSCHAFT (DE) 2000-06-13 — — US disclosed
US-6048885-A FUNGICIDES SHIONOGI & CO., LTD. (JP) 2000-04-11 — — US disclosed
US-5981532-A FOR CONTROLLING FUNGI, INSECTS, NEMATODES AND SPIDER MITES BASF AKTIENGESELLSCHAFT (DE) 1999-11-09 — — US disclosed
US-5824705-A FUNGICIDES BASF AKTIENGESELLSCHAFT (DE) 1998-10-20 — — US disclosed
CN-1144524-A Oxime derivative and fungicide containing the same as active ingredient SHIONOGI & CO (JP) 1997-03-05 — — CN disclosed
EP-0754684-A1 OXIME DERIVATIVE AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT SHIONOGI & CO., LTD. (JP) 1997-01-22 — — EP disclosed
US-5387607-A Fungicides BASF AKTIENGESELLSCHAFT (DE) 1995-02-07 — — US disclosed
US-5292759-A O-benzyloxime ethers and crop protection agents containing these compounds BASF AKTIENGESELLSCHAFT (DE) 1994-03-08 — — US disclosed
US-5194662-A Insecticides, fungicides for plants BASF AKTIENGESELLSCHAFT (DE) 1993-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120329812-A1 CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF KMO, KYNU, MAOA NPFFR2 2564/4885MEN1 2218/4885KMT2A 111/4885
US-20150299146-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF RTN3, CYCS, ATL3 NPFFR2 3050/4885MEN1 2138/4885KMT2A 3298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback